JULY 3, 2026 AT 02:29 PM

UK's MHRA says semaglutide injection approved to treat metabolic-associated steatohepatitis in adults with moderate-to-advanced liver fibrosis

ByNewsquawk Staff

Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.

#EU SESSION#US SESSION#GLOBAL EQUITIES

© 2026 Newsquawk. All rights reserved.